Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 6/16/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Elaine Mardis?

Elaine R. Mardis

Senior Research Scientist

Bio-Rad Laboratories Inc

HQ Phone:  (510) 724-7000

Email: e***@***.com

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Bio-Rad Laboratories Inc

1000 Alfred Nobel Drive

Hercules, California,94547

United States

Company Description

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) develops, manufactures, and markets a broad range of innovative products and solutions for the life science research and clinical diagnostic markets. The company is renowned for its commitment to quality and cust...more

Background Information

Employment History

Member, Faculty

Washington University School of Medicine


Member, Faculty

The Ohio State University


Co-Director

Genome Sequencing Center


Affiliations

CGEn

Scientific Advisory Board Member


Children's Discovery Institute

Associate Professor of Genetics


Siteman Cancer Center research

Member


American Association for Cancer Research Inc

Board Member


Washington University

Co-Director


dnanexus inc.

Scientific Advisory Boards


QIAGEN N.V.

Scientific Advisory Boards


Molecular Case Studies

Editorial Board Member


Orion Genomics LLC

Scientific Advisor


Pacific Biosciences of California , Inc.

Scientific Advisory Boards


Ingenuity Systems Inc

Scientific Advisory Board Member


Edge Biosystems Inc

Scientific Advisory Boards


Applied Biosystems Inc.

Board Member


American Society of Human Genetics

Member


Applera Corporation

Board Member


Disease Models

Editorial Board Member of Molecular Cancer Research


Discovery Institute

Member


AGBT-Precision Health

Organizing Committee


AACR

Board Member


Education

B.S.

Zoology

Oklahoma University


Ph.D.

National Human Genome Research Institute


Ph.D.

The Genome Institute of Washington University


Ph.D.

Washington University School of Medicine


Ph.D.

Biochemistry and Chemistry

University of Oklahoma


PhD

Scripps Translational Science Institute


PhD

The Genome Institute at Washington University


Web References(168 Total References)


ZS Genetics Management Team

www.zsgenetics.com [cached]

Elaine R. Mardis, PhD (SAB Chair)
Dr. Elaine Mardis graduated Phi Beta Kappa from the University of Oklahoma with a B.S. degree in zoology. She then completed her Ph.D. in Chemistry and Biochemistry in 1989, also at Oklahoma. Following graduation, Dr. Mardis was a senior research scientist for four years at BioRad Laboratories in Hercules, CA. In 1993, Dr. Mardis joined The Genome Institute at Washington University School of Medicine. As Director of Technology Development, she helped create methods and automation pipelines for sequencing the Human Genome. She currently orchestrates the Center's efforts to explore massively parallel sequencing technologies and to transition them into production sequencing capabilities as well as new applications. Dr. Mardis has research interests in the application of DNA sequencing to characterize cancer genomes and transcriptomes, and using these data to support therapeutic decision-making. She also is interested in facilitating the translation of basic science discoveries about human disease into the clinical setting. Dr. Mardis serves as an editorial board member of Molecular Cancer Research, Genome Research and Molecular Oncology, and acts as a reviewer for Nature, the New England Journal of Medicine, Cell and Genome Research. She serves on the scientific advisory boards of Qiagen Ingenuity, DNA Nexus, and ZS Genetics. Dr. Mardis received the Scripps Translational Research award for her work on cancer genomics in 2010, and was named a Distinguished Alumni of the University of Oklahoma College of Arts and Sciences for 2011. She is the former chair of Basic and Translational Sciences for the American College of Surgeons Oncology Group (ACOSOG). Further information is available on Dr. Mardis at genome.wustl.edu/people/individual/elaine-mardis/.


Scientific Advisory Board - Ingenuity

www.ingenuity.com [cached]

Elaine Mardis
Elaine R. Mardis, Ph.D. Professor of Genetics and Molecular Microbiology. Co-director, The Genome Institute at Washington University School of Medicine. Elaine Mardis graduated Phi Beta Kappa from the University of Oklahoma with a B.S. degree in zoology. She then completed her Ph.D. in Chemistry and Biochemistry in 1989, also at Oklahoma. Following graduation, Dr. Mardis was a senior research scientist for four years at BioRad Laboratories in Hercules, CA. In 1993, Dr. Mardis joined The Genome Institute at Washington University School of Medicine. As Director of Technology Development, she helped create methods and automation pipelines for sequencing the Human Genome. She currently orchestrates the Center's efforts to explore massively parallel sequencing technologies and to transition them into production sequencing capabilities as well as new applications. Dr. Mardis has research interests in the application of DNA sequencing to characterize cancer genomes and transcriptomes, and using these data to support therapeutic decision-making. She also is interested in facilitating the translation of basic science discoveries about human disease into the clinical setting. Dr. Mardis serves as an editorial board member of Molecular Cancer Research, Genome Research and Molecular Oncology, and acts as a reviewer for Nature, the New England Journal of Medicine, Cell and Genome Research. She serves on the scientific advisory boards of Pacific Biosciences, Inc., DNA Nexus, and ZS Genetics. Dr. Mardis received the Scripps Translational Research award for her work on cancer genomics in 2010, and was named a Distinguished Alumni of the University of Oklahoma College of Arts and Sciences for 2011. She is the former chair of Basic and Translational Sciences for the American College of Surgeons Oncology Group (ACOSOG).


ZS Genetics - Our Team

www.zsgenetics.com [cached]

Elaine R. Mardis, PhD (SAB Chair) A renowned researcher in the application of DNA sequencing to characterize cancer genomes and the transition of basic science human disease discoveries into the clinical setting, Dr. Mardis is Professor of Genetics and Molecular Microbiology, and the Co-Director of The Genome Institute at Washington University School of Medicine.
In 1993, Dr. Mardis joined The Genome Institute. As Director of Technology Development, she helped create methods and automation piplines for sequencing the Human Genome. She currently orchestrates the Center's efforts to explore massively parallel sequencing technologies. Dr. Mardis received her BS in Zoology, Phi Beta Kappa, from the University of Oklahoma, along with her Ph.D. in Chemistry and Biochemistry. Following graduation, Dr. Mardis was a senior research scientist at BioRad Laboratories. Widely published, Dr. Mardis serves on several NIH study section, is an editorial board member of Genome Research and Molecular Oncology, and acts as a reviewer for Nature and Genome Research. She has recieved various awards, including the Scripps Translational Research award for her work on cancer genomics in 2010. Further information is available on Dr. Mardis at genome.wustl.edu/people/individual/elaine-mardis/.


2017 Precision Health Speakers | AGBT

www.agbt.org [cached]

Elaine Mardis, PHD
The Institute for Genomic Medicine at Nationwide Children's Hospital Elaine Mardis, PhD, graduated from the University of Oklahoma with a B.S. in Zoology and completed her Ph.D. in Chemistry and Biochemistry in 1989, also at Oklahoma. Dr. Mardis was a senior research scientist for four years at BioRad Laboratories. She joined the faculty of Washington University School of Medicine in 1993 and has served as Co-director of the McDonnell Genome Institute since 2002. In 2014, Dr. Mardis was named the Robert E. and Louise F. Dunn Distinguished Professor of Medicine. In September 2016, Dr. Mardis was named the co-Executive Director of the Institute for Genomic Medicine at Nationwide Children's Hospital in Columbus, Ohio, where she also joined the faculty of the Ohio State University as Professor of Pediatrics.


2016 Precision Health Meeting Speakers | AGBT

www.agbt.org [cached]

Elaine Mardis, Ph.D., graduated Phi Beta Kappa from the University of Oklahoma with a B.S. degree in zoology.
She then completed her Ph.D. in Chemistry and Biochemistry in 1989, also at Oklahoma. Following graduation, Dr. Mardis was a senior research scientist for four years at BioRad Laboratories in Hercules, CA. In 1993, Dr. Mardis joined the faculty at Washington University School of Medicine. Recruited for her expertise in DNA sequencing and automation technology, she served as Director of Technology Development at the (then) Washington University Genome Sequencing Center, helping create methods and automation pipelines for sequencing the Human Genome. She has served as Co-director of the McDonnell Genome Institute since 2002. In 2014, Dr. Mardis was named the Robert E. and Louise F. Dunn Distinguished Professor of Medicine. Dr. Mardis has research interests in the application of next-generation sequencing to characterize cancer genomes and transcriptomes, and using these data to support therapeutic decision-making. She co-led the teams that first used next-generation sequencing to characterize the whole genome of an AML patient (Nature 2008), first sequenced and compared a primary tumor to its metastasis and xenograft, and first reported whole genome sequencing of samples from a breast cancer clinical trial. Beyond cancer genomics discoveries, Dr. Mardis is leading efforts to facilitate the translation of basic science discoveries about human genetic diseases into the clinical setting, especially focused on the use of next-generation sequencing. Her translational research efforts aim to devise NGS-based diagnostics, decision-support tools and databases, and the use of genomics to design personalized cancer vaccines. Dr. Mardis was elected to the AACR Board of Directors in 2015. She serves as an associate editor of Molecular Cancer Research, Disease Models and Mechanisms and Annals of Oncology, and acts as a reviewer for Nature, the New England Journal, Cell and Science. She is the Editor-in-Chief of Molecular Case Studies. She serves on the scientific advisory boards of Qiagen Ingenuity, DNA Nexus, and ZS Genetics, and is a member of the Supervisory Board of Qiagen N.V. Dr. Mardis received the 2010 Scripps Translational Research award for her work on cancer genomics, and was named a Distinguished Alumni of the University of Oklahoma College of Arts and Sciences in 2011. Discover Magazine featured her work in cancer genomics as one of their top 100 science stories of 2013. In 2014 and 2015, she was one of the most highly cited researchers in the world, according to Thompson-Reuters. She will receive the Morton K. Schwartz award from the American Association of Clinical Chemistry for Significant Contributions in Cancer Research Diagnostics in 2016.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory